Ashley Cowan is a pharmacist who is specialized in Ambulatory Care in Griffin, Georgia. Patients can reach her at 601 S 8th St, Griffin or contact her on 770-229-6910. Active license number of Ashley Cowan is RPH030960 for Ambulatory Care in Georgia. Ashley Cowan is a licensed pharmacist who has demonstrated specialized knowledge and skill in the provision of integrated, accessible health care services by pharmacists and is accountable for addressing medication needs, developing sustained partnerships with patients, and practicing in the context of family and community.
Complete Profile:
Ashley Cowan speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Ashley Cowan
Specialization:
Ambulatory Care
Gender:
Female
Location:
601 S 8th St, Griffin, Georgia, 30224-4213
Phone:
770-229-6910
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Ashley Cowan are as mentioned below.
NPI Number:
1861035677
NPI Enumeration Date:
24 Oct, 2019
NPI Last Update On:
24 Oct, 2019
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Ashley Cowan are as mentioned below.
Specialization
License Number
State
Status
Ambulatory Care
RPH030960
Georgia
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
601 S 8th St, Griffin, Georgia
Zip:
30224-4213
Phone Number:
--
Fax Number:
--
Patients can reach Ashley Cowan at 601 S 8th St, Griffin, Georgia or can call on phone at 770-229-6910.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.